🌐 aficamten
Aficamten is a clinical-stage cardiac myosin inhibitor being monitored globally for its development and regulatory progress as a potential treatment for obstructive hypertrophic cardiomyopathy.
1
Signals
1
Articles
Linked Signals
| Signal | Status | Lens | Role | Confidence | Last Seen |
|---|---|---|---|---|---|
| Nautical Institute UAE Branch puts seafarer welfare centre stage at Marine Ball 2026 | active | Health | responder | 100% |